Our Team

Built by experts in health economics, AI, and pharma

A founding team with deep domain expertise across health economics, AI engineering, and decades of pharmaceutical commercialization.

Allan Tran, PhD

Allan Tran, PhD

CEO & Co-Founder

Allan is a Health Economist who completed his PhD at the University of Toronto. His research examines the impacts of unexpected out-of-pocket costs and claim denials for preventive care on patient outcomes and health equity. He brings prior HEOR experience from Novartis and Analysis Group.

Theodore J. Witek Jr., DrPH, MBA

Theodore J. Witek Jr., DrPH, MBA

COO & Co-Founder

Decades of successful drug development and commercialization along the pharma/biotech value chain with CSO and CEO insights. He has managed some of the pharma sector's largest strategic alliances. He is currently a Full Professor and Program Director at the University of Toronto, where he guides the next generation of innovators.

Alexander Hoagland, PhD

Alexander Hoagland, PhD

Data Operations Lead & Co-Founder

Professor Hoagland is a Health Economist at the University of Toronto whose research focuses on claim denials and unexpected out-of-pocket costs for preventive care in the United States. He has published extensively on the economic drivers and consequences of these billing practices.

AG

Anil Gaddam, M.Eng

Founding Engineer

Anil is a software and machine learning engineer with nearly a decade of experience building production systems at scale. He holds a Master of Engineering in Machine Learning from McGill University and has led large-scale software, data, and AI initiatives at a major national telecommunications provider, with expertise spanning full-stack engineering, data platforms, and cutting-edge AI agents and intelligent systems.

PA

Paul Arora, PhD

Advisor

Adjunct Professor at the University of Toronto's Dalla Lana School of Public Health. Founded and exited numerous consulting firms including LightHouse Outcomes Inc. (acquired by Cytel) and Inka Health. Currently serves on the Scientific Advisory Board of Onco-Innovations.

HL

Harry Levy, MD, MPH

Advisor

Preventive care physician and digital health pioneer. Founder & CEO of interMDnet, built over 20+ years in partnership with Albert Einstein College of Medicine and faculty from 15 U.S. medical schools. Brings deep clinical and entrepreneurial insight to the platform.

KB

Kenny Bahia, MD

Advisor

Physician specializing in organizational effectiveness. Advises on business development, platform strategy, and supporting effective software integration within provider practices. Founded his own consulting firm and has advised Fortune 100 companies.

SS

Steve Stefano

Advisor

Pharmaceutical executive with decades of experience in U.S. payer reimbursement and market access. Previously led GSK's US Payer Market Division, served as Managing Director of Ashfield Market Access, and founded SynopiaRx.

JO

James Obaji, MD

Clinical Operations

Dr. Obaji is a practicing family physician in Ontario and continues to see patients alongside his work at Aletheia. He brings frontline experience of FHO billing, premium and incentive coding, and day-to-day clinic workflow to the platform, and leads pilot deployment and clinical validation with primary care practices across the province.

JF

Jamie Firsten, LL.B.

Legal Counsel

Jamie is a corporate lawyer and partner in the Business Law Group at Goodmans LLP, where he advises technology companies on venture financings, mergers and acquisitions, and corporate matters. He also serves as legal counsel in residence at the DMZ, Toronto Metropolitan University's startup incubator. He holds an LL.B. from the University of Windsor and has been recognized by Chambers Canada, Best Lawyers in Canada, and Lexpert's Rising Stars.

Founded by alumni of

University of Toronto
McGill University
Yale University
NYU
University of Waterloo
Boston University
GSK
Boehringer
CUSPS
University of Toronto
McGill University
Yale University
NYU
University of Waterloo
Boston University
GSK
Boehringer
CUSPS